Not Tagged
Not Tagged
['nsclc', 'sclc']
a patient with pd-1 resistant erbb2 amplified nsclc responded after 8 weeks of monotherapy, with liver mets reducing from 47 to 10 mm #asco23
We are a clinical-stage company developing drugs targeting natural killer cells & other cells of the innate immune system, to eliminate cancer & other diseases.